Amazon S3 on MSN
A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...
The Nigerian Government has reached a landmark agreement for reduction in price of twice-yearly HIV prevention injection, ...
The Federal Government, through the National Agency for the Control of AIDS (NACA), has joined global leaders to endorse a ...
Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...
A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce ...
2d
Gilead drug deal opens door for $40-a-year generic version of groundbreaking HIV prevention overseas
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...
Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...
Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback